학술논문
BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib
Document Type
Artikel
Author
Bonfiglio, S; Sutton, LA; Ljungstrom, V; Capasso, A; Pandzic, T; Westrom, S; Foroughi-Asl, H; Skaftason, A; Gellerbring, A; Lyander, A; Gandini, F; Gaidano, G; Trentin, L; Bonello, L; Reda, G; Bodor, C; Stavroyianni, N; Tam, CS; Marasca, R; Forconi, F; Panayiotidis, P; Ringshausen, I; Jaksic, O; Frustaci, AM; Iyengar, S; Coscia, M; Mulligan, SP; Ysebaert, L; Strugov, V; Pavlovsky, C; Walewska, R; Osterborg, A; Cortese, D; Ranghetti, P; Baliakas, P; Stamatopoulos, K; Scarfo, L; Rosenquist, R; Ghia, P
Source
Blood advances. 7(12):2794-2806
Subject
Language
English
English
English
ISSN
2473-9537